<DOC>
	<DOCNO>NCT01374217</DOCNO>
	<brief_summary>The primary objective study evaluate anti-tumor efficacy tadalafil combination Lenalidomide/dexamethasone ( Rd ) multiple myeloma .</brief_summary>
	<brief_title>Administration Tadalafil Conjunction With Lenalidomide Dexamethasone Patients With Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Progressive myeloma define International Uniform Criteria . Currently Lenalidomide dexamethasone treatment myeloma Age &gt; 18 year . Measurable paraprotein serum urine detectable free light chain serum . ECOG performance status 0 2 . Hypersensitivity PDE5 inhibitor tadalafil , sildenafil vardenafil . History malignancy multiple myeloma last five year , except adequately treat basal squamous cell skin cancer . Participation clinical trial involve investigational drug device four week prior . Infection require treatment antibiotic , antifungal , antiviral agent last seven day Any evidence severe uncontrolled systemic disease ( e.g. , unstable uncompensated respiratory , cardiac , hepatic , renal disease ) . History significant hypotensive episode require hospitalization . Acute myocardial infarction within prior 3 month , uncontrolled angina Uncontrolled arrhythmia , uncontrolled congestive heart failure History follow cardiac condition : I. Angina require treatment longacting nitrate . II . Angina require treatment shortacting nitrate within 90 day plan tadalafil administration . III . Unstable angina within 90 day visit 1 . IV . Positive cardiac stress test without document evidence subsequent , effective cardiac intervention . History follow coronary condition within 90 day plan tadalafil administration : i. Myocardial Infarction . ii . Coronary artery bypass graft surgery . iii . Percutaneous coronary intervention ( example , angioplasty stent placement ) . iv . Any evidence heart disease ( NYHAâ‰¥Class III ) within 6 month plan tadalafil administration . Current treatment nitrate . Current systemic treatment potent cytochrome P450 3A4 ( CYP3A4 ) inhibitor ketoconazole ritonavir . Prior chronic immune suppressive state ( AIDS , immunosuppressive therapy ) . History hypotension and/or blindness sudden decrease/loss hearing prior treatment PDE5 inhibitor . Prior history nonarterial ischemic optic retinopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>